Loading...

Norah Terrault, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
Address513 Parnassus Avenue
San Francisco CA 94117
Phone415-476-2227
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPost-Doc Fellow/Scholar1995 Medicine
    University of California, San Francisco Clinical Fellowship Gastroenterology
    University of California, San FranciscoResidency
    University of AlbertaM.D.1987School of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Bay Area Hepatitis C Cooperative Research Center
    NIH U19AI088790Jun 15, 2010 - May 31, 2015
    Role: Co-Investigator
    Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    NIH/NIDDK U01DK082944Sep 30, 2008 - May 31, 2020
    Role: Principal Investigator
    Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
    NIH/NIDDK U01DK061738Jun 15, 2002 - Jun 30, 2019
    Role: Principal Investigator
    Resistance to Antiviral Therapy in Chronic Hepatitis C
    NIH/NIDDK U01DK060346Aug 1, 2001 - Apr 30, 2007
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lee BP, Terrault N. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant. 2018 Apr; 23(2):229-236. PMID: 29389821.
      View in: PubMed
    2. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault N, Lisker-Melman M, Sanyal A, Lok AS. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care. 2018 Mar 29. PMID: 29599296.
      View in: PubMed
    3. Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. Clin Gastroenterol Hepatol. 2018 Mar 14. PMID: 29378307.
      View in: PubMed
    4. El-Sherif O, Jiang ZG, Tapper EB, Huang KC, Zhong A, Osinusi A, Charlton M, Manns M, Afdhal NH, Mukamal K, McHutchison J, Brainard DM, Terrault N, Curry MP. Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection. Gastroenterology. 2018 Mar 10. PMID: 29535028.
      View in: PubMed
    5. Huang AC, Mehta N, Dodge JL, Yao FY, Terrault N. Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout. Hepatology. 2018 Feb 24. PMID: 29476694.
      View in: PubMed
    6. Hameed B, Terrault N, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML. Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2018 Mar; 47(5):645-656. PMID: 29333665.
      View in: PubMed
    7. Lim JK, Liapakis AM, Shiffman ML, Lok AS, Zeuzem S, Terrault N, Park JS, Landis CS, Hassan M, Gallant J, Kuo A, Pockros PJ, Vainorius M, Akushevich L, Michael L, Fried MW, Nelson DR, Ben-Ari Z. Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol. 2018 Jan 03. PMID: 29306043.
      View in: PubMed
    8. Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault N. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient. Transpl Infect Dis. 2018 Feb; 20(1). PMID: 29125670.
      View in: PubMed
    9. Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR, Terrault N, Fox AN, DiMartini AF. Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study. Transplantation. 2018 Jan; 102(1):105-118. PMID: 28885494.
      View in: PubMed
    10. Chhatwal J, Samur S, Bethea ED, Ayer T, Kanwal F, Hur C, Roberts MS, Terrault N, Chung RT. Transplanting HCV-positive livers into HCV-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2017 Dec 09. PMID: 29222916.
      View in: PubMed
    11. Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study. Hepatology. 2017 10; 66(4):1090-1101. PMID: 28504842.
      View in: PubMed
    12. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault N. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 09; 101(9):2079-2082. PMID: 28880197.
      View in: PubMed
    13. VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault N, Siddique J. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017 11; 153(5):1260-1272.e3. PMID: 28802566.
      View in: PubMed
    14. Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant. 2017 Nov; 17(11):2790-2802. PMID: 28556422.
      View in: PubMed
    15. Zhou K, Terrault N. Management of hepatitis B in special populations. Best Pract Res Clin Gastroenterol. 2017 Jun; 31(3):311-320. PMID: 28774413.
      View in: PubMed
    16. Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Müllhaupt B. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant. Ann Hepatol. 2017 May - Jun; 16(3):375-381. PMID: 28425407.
      View in: PubMed
    17. Ajmera VH, Terrault N, Harrison SA. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017 06; 65(6):2090-2099. PMID: 28100008.
      View in: PubMed
    18. Sarkar M, Wellons M, Cedars MI, VanWagner L, Gunderson EP, Ajmera V, Torchen L, Siscovick D, Carr JJ, Terry JG, Rinella M, Lewis CE, Terrault N. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. Am J Gastroenterol. 2017 May; 112(5):755-762. PMID: 28291240.
      View in: PubMed
    19. Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, Younossi Z. Hepatitis C virus infection. Nat Rev Dis Primers. 2017 Mar 02; 3:17006. PMID: 28252637.
      View in: PubMed
    20. Terrault N, McCaughan GW, Curry MP, Gane E, Fagiuoli S, Fung J, Agarwal K, Lilly L, Strasser SI, Brown K, Gadano A, Kwo PY, Burra P, Samuel D, Charlton M, Pessoa MG, Berenguer M. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES. Transplantation. 2017 Mar 01. PMID: 28252565.
      View in: PubMed
    21. Terrault N, Berenguer M, Strasser S, Gadano A, Lilly L, Samuel D, Kwo PY, Agarwal K, Curry M, Fagiuoli S, Fung JY, Gane E, Brown KA, Burra P, Charlton M, Pessoa M, McCaughan GW. International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 2017 Mar 01. PMID: 28252566.
      View in: PubMed
    22. Walsh CE, Workowski K, Terrault N, Sax PE, Cohen A, Bowlus CL, Kim AY, Hyland RH, Han B, Wang J, Stamm LM, Brainard DM, McHutchison JG, von Drygalski A, Rhame F, Fried MW, Kouides P, Balba G, Reddy KR. Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders. Haemophilia. 2017 Mar; 23(2):198-206. PMID: 28124511.
      View in: PubMed
    23. Butt Z, Dew MA, Liu Q, Simpson MA, Smith AR, Zee J, Gillespie BW, Abbey SE, Ladner DP, Weinrieb R, Fisher RA, Hafliger S, Terrault N, Burton J, Sherker AH, Di Martini A. Psychological Outcomes of Living Liver Donors From a Multicenter Prospective Study: Results From the Adult-to-Adult Living Donor Liver Transplantation Cohort Study2 (A2ALL-2). Am J Transplant. 2017 May; 17(5):1267-1277. PMID: 27865040.
      View in: PubMed
    24. Flemming JA, Kim WR, Brosgart CL, Terrault N. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology. 2017 03; 65(3):804-812. PMID: 28012259.
      View in: PubMed
    25. Levitsky J, Verna EC, O'Leary JG, Bzowej NH, Moonka DK, Hyland RH, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N. Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients. N Engl J Med. 2016 11 24; 375(21):2106-2108. PMID: 27959735.
      View in: PubMed
    26. Reddy KR, Lim JK, Kuo A, Di Bisceglie AM, Galati JS, Morelli G, Everson GT, Kwo PY, Brown RS, Sulkowski MS, Akuschevich L, Lok AS, Pockros PJ, Vainorius M, Terrault N, Nelson DR, Fried MW, Manns MP. All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database. Aliment Pharmacol Ther. 2017 01; 45(1):115-126. PMID: 27790729.
      View in: PubMed
    27. Ajmera V, Perito ER, Bass NM, Terrault N, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat B, et al. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017 01; 65(1):65-77. PMID: 27532276.
      View in: PubMed
    28. Terrault N, Hassanein TI. Management of the patient with SVR. J Hepatol. 2016 Oct; 65(1 Suppl):S120-S129. PMID: 27641982.
      View in: PubMed
    29. Terrault N. Real-World Experiences with Tenofovir Disoproxil Fumarate: Is this the "B-Ticket"? Dig Dis Sci. 2016 10; 61(10):2770-2772. PMID: 27565507.
      View in: PubMed
    30. Terrault N, Zeuzem S, Di Bisceglie AM, Lim JK, Pockros PJ, Frazier LM, Kuo A, Lok AS, Shiffman ML, Ben Ari Z, Akushevich L, Vainorius M, Sulkowski MS, Fried MW, Nelson DR. Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response. Gastroenterology. 2016 12; 151(6):1131-1140.e5. PMID: 27565882.
      View in: PubMed
    31. Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, Klair J, Terrault N, Clark JM, Unalp-Arida A, Diehl AM, Suzuki A. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2017 01; 15(1):127-131.e2. PMID: 27523635.
      View in: PubMed
    32. Campos-Varela I, Dodge JL, Stock PG, Terrault N. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus. Clin Transplant. 2016 Sep; 30(9):1140-5. PMID: 27411037.
      View in: PubMed
    33. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9. PMID: 27236153.
      View in: PubMed
    34. Nathanson MH, Terrault N. Hepatitis B surface antigen loss: Not all that we hoped it would be. Hepatology. 2016 08; 64(2):328-9. PMID: 27178231.
      View in: PubMed
    35. Giard JM, Terrault N. Women with Cirrhosis: Prevalence, Natural History, and Management. Gastroenterol Clin North Am. 2016 06; 45(2):345-58. PMID: 27261903.
      View in: PubMed
    36. Chen T, Terrault N. Treatment of chronic hepatitis C in patients with cirrhosis. Curr Opin Gastroenterol. 2016 May; 32(3):143-51. PMID: 27023162.
      View in: PubMed
    37. Campos-Varela I, Moreno A, Morbey A, Guaraldi G, Hasson H, Bhamidimarri KR, Castells L, Grewal P, Baños I, Bellot P, Brainard DM, McHutchison JG, Terrault N. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy. Aliment Pharmacol Ther. 2016 06; 43(12):1319-29. PMID: 27098374.
      View in: PubMed
    38. Soriano V, Young B, Terrault N. Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016. AIDS Rev. 2016 Apr-Jun; 18(2):81-8. PMID: 27196355.
      View in: PubMed
    39. Chen T, Terrault N. Perspectives on treating hepatitis C infection in the liver transplantation setting. Curr Opin Organ Transplant. 2016 Apr; 21(2):111-9. PMID: 26927201.
      View in: PubMed
    40. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault N, Feng S. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation. Liver Int. 2016 Apr; 36(4):611. PMID: 26584013.
      View in: PubMed
    41. Terrault N. The changing 'face' of wait-listed patients in the USA. Curr Opin Organ Transplant. 2016 Apr; 21(2):89-90. PMID: 26890533.
      View in: PubMed
    42. Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, Liapakis A, Nelson DR, Fried MW, Terrault N. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016 06; 36(6):807-16. PMID: 26923436.
      View in: PubMed
    43. Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault N. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 May; 111(5):658-64. PMID: 27002796; PMCID: PMC4860097.
    44. Hameed B, Terrault N. Emerging Therapies for Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016 May; 20(2):365-85. PMID: 27063275.
      View in: PubMed
    45. Brown RS, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault N. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. Liver Transpl. 2016 Jan; 22(1):24-33. PMID: 26519873.
      View in: PubMed
    46. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5. PMID: 26684441.
      View in: PubMed
    47. Terrault N, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan; 63(1):261-83. PMID: 26566064.
      View in: PubMed
    48. Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault N, Wiktor S. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies. Gut. 2015 Nov; 64(11):1824-33. PMID: 26449729.
      View in: PubMed
    49. Khalili M, Lombardero M, Chung RT, Terrault N, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74. PMID: 26390278; PMCID: PMC4762364 [Available on 11/01/16].
    50. Lanini S, Nanni Costa A, Grossi PA, Procaccio F, Ricci A, Capobianchi MR, Terrault N, Ippolito G. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis. Liver Int. 2016 Mar; 36(3):410-7. PMID: 26264452.
      View in: PubMed
    51. Flemming JA, Saxena V, Shen H, Terrault N, Rongey C. Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA. Dig Dis Sci. 2016 Jan; 61(1):62-9. PMID: 26363933; PMCID: PMC4809672 [Available on 01/01/17].
    52. Terrault N, Monto A, Stinchon MR, Rusie E, Moreo K. New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo. J Manag Care Spec Pharm. 2015 Sep; 21(9):S1-14. PMID: 26308363.
      View in: PubMed
    53. Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault N, Biggins SW. The corrected donor age for hepatitis C virus-infected liver transplant recipients. Liver Transpl. 2015 Aug; 21(8):1022-30. PMID: 26074140; PMCID: PMC4809736.
    54. Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault N. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation. 2015 Aug; 99(8):1644-51. PMID: 25715116; PMCID: PMC4818984.
    55. Ho CK, Boscardin CK, Gleason N, Collado D, Terdiman J, Terrault N, Gonzales R. Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method. J Eval Clin Pract. 2016 Feb; 22(1):46-52. PMID: 26223584.
      View in: PubMed
    56. Saxena V, Nyberg L, Pauly M, Dasgupta A, Nyberg A, Piasecki B, Winston B, Redd J, Ready J, Terrault N. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis. Hepatology. 2015 Sep; 62(3):715-25. PMID: 26033798; PMCID: PMC4549204.
    57. Saxena V, Terrault N. Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients. Clin Liver Dis. 2015 Nov; 19(4):669-88, vi. PMID: 26466655.
      View in: PubMed
    58. Giard JM, Terrault N. Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):2002-4. PMID: 26192143; PMCID: PMC4615527 [Available on 11/01/16].
    59. Terrault N. Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era? Hepatology. 2015 Jul; 62(1):4-7. PMID: 25965110.
      View in: PubMed
    60. Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS, Fried MW, Terrault N, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. Gastroenterology. 2015 Sep; 149(3):649-59. PMID: 25985734.
      View in: PubMed
    61. Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault N. Hepatitis C genotype influences post-liver transplant outcomes. Transplantation. 2015 Apr; 99(4):835-40. PMID: 25211520; PMCID: PMC4672637.
    62. Price JC, Terrault N. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34. PMID: 25604355.
      View in: PubMed
    63. Saxena V, Terrault N. Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander? Dig Dis Sci. 2015 Apr; 60(4):806-9. PMID: 25586091; PMCID: PMC4422509.
    64. Lai JC, Bikle DD, Lizaola B, Hayssen H, Terrault N, Schwartz JB. Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int. 2015 Oct; 35(10):2294-300. PMID: 25757956; PMCID: PMC4567539 [Available on 10/01/16].
    65. Stock PG, Terrault N. Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle. Hepatology. 2015 May; 61(5):1747-54. PMID: 25292153.
      View in: PubMed
    66. Ho CK, Maselli JH, Terrault N, Gonzales R. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments. Dig Dis Sci. 2015 Jul; 60(7):2183-9. PMID: 25724166; PMCID: PMC4797948.
    67. Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault N, Feng S. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Liver Int. 2015 Sep; 35(9):2167-73. PMID: 25644788.
      View in: PubMed
    68. Campos-Varela I, Straley S, Agudelo EZ, Carlson L, Terrault N. Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients. Liver Transpl. 2015 Feb; 21(2):272-4. PMID: 25332190; PMCID: PMC4562280.
    69. Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? Hepatology. 2015 Feb; 61(2):703-11. PMID: 25412906.
      View in: PubMed
    70. Goel A, Terrault N. Reply: To PMID 25045002. Liver Transpl. 2015 Mar; 21(3):416. PMID: 25530165.
      View in: PubMed
    71. Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault N. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci. 2015 Jun; 60(6):1813-9. PMID: 25563723; PMCID: PMC4797945.
    72. Price JC, Terrault N. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8. PMID: 25183500.
      View in: PubMed
    73. Flemming JA, Kim WR, Terrault N. Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation? Cancer. 2015 Apr 01; 121(7):1150. PMID: 25470366.
      View in: PubMed
    74. Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015 Apr; 62(4):946-55. PMID: 25433162.
      View in: PubMed
    75. Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le NT, Li L, Mei J, Terrault N, Kamili S. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots. J Virol Methods. 2015 Feb; 212:66-70. PMID: 25445800.
      View in: PubMed
    76. Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R, Gordon F, Levitsky J, Terrault N, Burton JR, Xie W, Setze C, Badri P, Pilot-Matias T, Vilchez RA, Forns X. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82. PMID: 25386767.
      View in: PubMed
    77. Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015 Mar 14; 385(9972):956-65. PMID: 25468160; PMCID: PMC4447192.
    78. Miro JM, Stock P, Teicher E, Duclos-Vallée JC, Terrault N, Rimola A. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update. J Hepatol. 2015 Mar; 62(3):701-11. PMID: 25450714.
      View in: PubMed
    79. Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault N. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. Gastroenterology. 2015 Jan; 148(1):108-17. PMID: 25304641.
      View in: PubMed
    80. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8. PMID: 25045002; PMCID: PMC4804463.
    81. Curry MP, Forns X, Chung RT, Terrault N, Brown R, Fenkel JM, Gordon F, O'Leary J, Kuo A, Schiano T, Everson G, Schiff E, Befeler A, Gane E, Saab S, McHutchison JG, Subramanian GM, Symonds WT, Denning J, McNair L, Arterburn S, Svarovskaia E, Moonka D, Afdhal N. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Gastroenterology. 2015 Jan; 148(1):100-107.e1. PMID: 25261839.
      View in: PubMed
    82. Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, Inadomi J, Terrault N, Rosen HR. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index. Am J Transplant. 2014 Nov; 14(11):2588-94. PMID: 25243648; PMCID: PMC4205189.
    83. Campos-Varela I, Peters MG, Terrault N. Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting. Clin Infect Dis. 2015 Jan 01; 60(1):108-16. PMID: 25228702.
      View in: PubMed
    84. Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault N. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience. Liver Transpl. 2014 Oct; 20(10):1202-10. PMID: 24961679; PMCID: PMC4803440.
    85. Terrault N, Stock PG. Management of hepatitis C in kidney transplant patients: on the cusp of change. Am J Transplant. 2014 Sep; 14(9):1955-7. PMID: 25307029.
      View in: PubMed
    86. Flemming JA, Yang JD, Vittinghoff E, Kim WR, Terrault N. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer. 2014 Nov 15; 120(22):3485-93. PMID: 25042049; PMCID: PMC4553222.
    87. Terrault N, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol. 2014 Dec; 61(6):1253-9. PMID: 25048952.
      View in: PubMed
    88. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault N, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. PMID: 25010003.
      View in: PubMed
    89. Lai JC, Feng S, Terrault N, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014 Aug; 14(8):1870-9. PMID: 24935609.
      View in: PubMed
    90. Saxena V, Monto A, Terrault N. Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals - authors' reply. Aliment Pharmacol Ther. 2014 Jun; 39(12):1428. PMID: 24849150.
      View in: PubMed
    91. Sarkar M, Terrault N. Ending vertical transmission of hepatitis B: the third trimester intervention. Hepatology. 2014 Aug; 60(2):448-51. PMID: 24668789.
      View in: PubMed
    92. Burton JR, O'Leary JG, Verna EC, Saxena V, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault N. A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. J Hepatol. 2014 Sep; 61(3):508-14. PMID: 24801415; PMCID: PMC4394742.
    93. Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat. 2014 Aug; 21(8):e74-7. PMID: 24773782; PMCID: PMC4082745.
    94. Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault N, Peters MG, Manos MM. Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci. 2014 Sep; 59(9):2100-8. PMID: 24728968; PMCID: PMC4149592.
    95. Saxena V, Manos MM, Yee HS, Catalli L, Wayne E, Murphy RC, Shvachko VA, Pauly MP, Chua J, Monto A, Terrault N. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. Aliment Pharmacol Ther. 2014 May; 39(10):1213-24. PMID: 24654657; PMCID: PMC4385588.
    96. Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients. Am J Transplant. 2014 May; 14(5):1129-35. PMID: 24636466.
      View in: PubMed
    97. Terrault N, Stravitz RT, Lok AS, Everson GT, Brown RS, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology. 2014 Apr; 59(4):1311-9. PMID: 24677192; PMCID: PMC4118586.
    98. Dodge JL, Terrault N. Sexual transmission of hepatitis C: A rare event among heterosexual couples. J Coagul Disord. 2014 Mar; 4(1):38-39. PMID: 26617979.
      View in: PubMed
    99. Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault N, Stotland N, Bikle D. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab. 2014 May; 99(5):1631-7. PMID: 24483159; PMCID: PMC4010704.
    100. Hartigan-O'Connor DJ, Lin D, Ryan JC, Shvachko VA, Cozen ML, Segal MR, Terrault N, Lanier LL, Manos MM, McCune JM. Monocyte activation by interferon a is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection. J Infect Dis. 2014 May 15; 209(10):1602-12. PMID: 24325966; PMCID: PMC3997582.
    101. Schwartz JB, Lai J, Lizaola B, Kane L, Weyland P, Terrault N, Stotland N, Bikle D. Variability in free 25(OH) vitamin D levels in clinical populations. J Steroid Biochem Mol Biol. 2014 Oct; 144 Pt A:156-8. PMID: 24240067; PMCID: PMC4022715.
    102. Harbell J, Terrault N, Stock P. Solid organ transplants in HIV-infected patients. Curr HIV/AIDS Rep. 2013 Sep; 10(3):217-25. PMID: 23893004.
      View in: PubMed
    103. Gordon SC, Hamzeh FM, Pockros PJ, Hoop RS, Buikema AR, Korner EJ, Terrault N. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease. Aliment Pharmacol Ther. 2013 Oct; 38(7):784-93. PMID: 23981040; PMCID: PMC4553220.
    104. Shores NJ, Dodge JL, Feng S, Terrault N. Donor Risk Index for African American liver transplant recipients with hepatitis C virus. Hepatology. 2013 Oct; 58(4):1263-9. PMID: 23696235; PMCID: PMC4561529.
    105. Terrault N, Dodge J, Alter M. Reply: To PMID 23175457. Hepatology. 2013 Sep; 58(3):1191. PMID: 23423961.
      View in: PubMed
    106. Freeman J, Emond J, Gillespie BW, Appelbaum PS, Weinrieb R, Hill-Callahan P, Gordon EJ, Terrault N, Trotter J, Ashworth A, Dew MA, Pruett T. Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant. 2013 Jul-Aug; 27(4):633-45. PMID: 23859354; PMCID: PMC4096778.
    107. Marcellin P, Cooper C, Balart L, Larrey D, Box T, Yoshida E, Lawitz E, Buggisch P, Ferenci P, Weltman M, Labriola-Tompkins E, Le Pogam S, Nájera I, Thomas D, Hooper G, Shulman NS, Zhang Y, Navarro MT, Lim CY, Brunda M, Terrault N, Yetzer ES. Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection. Gastroenterology. 2013 Oct; 145(4):790-800.e3. PMID: 23811112.
      View in: PubMed
    108. Terrault N. Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era? Am J Gastroenterol. 2013 Jun; 108(6):949-51. PMID: 23735916.
      View in: PubMed
    109. Lucey MR, Terrault N. Reply: To PMID 23281277. Liver Transpl. 2013 Jun; 19(6):672. PMID: 23559496.
      View in: PubMed
    110. Terrault N, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9. PMID: 23175457; PMCID: PMC4384338.
    111. Everson GT, Terrault N, Lok AS, Rodrigo del R, Brown RS, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology. 2013 May; 57(5):1752-62. PMID: 22821361; PMCID: PMC3510348.
    112. Biggins SW, Bambha KM, Terrault N, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl. 2012 Dec; 18(12):1471-8. PMID: 23008049; PMCID: PMC3518670.
    113. Flemming JA, Terrault N. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection. Infect Dis Clin North Am. 2012 Dec; 26(4):903-15. PMID: 23083823.
      View in: PubMed
    114. Driver TH, Terrault N, Saxena V. Acute hepatitis C in an HIV-infected patient: a case report and review of literature. J Gen Intern Med. 2013 May; 28(5):734-8. PMID: 23151989; PMCID: PMC3631075.
    115. Gordon SC, Pockros PJ, Terrault N, Hoop RS, Buikema A, Nerenz D, Hamzeh FM. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology. 2012 Nov; 56(5):1651-60. PMID: 22610658.
      View in: PubMed
    116. Nelson DR, Jensen DM, Sulkowski MS, Everson G, Fried MW, Gordon SC, Jacobson I, Reau NS, Sherman K, Terrault N, Thomas D. Hepatitis C virus: a critical appraisal of new approaches to therapy. Hepat Res Treat. 2012; 2012:138302. PMID: 23094146; PMCID: PMC3472509.
    117. Terrault N. Liver transplantation in the setting of chronic HCV. Best Pract Res Clin Gastroenterol. 2012 Aug; 26(4):531-48. PMID: 23199510.
      View in: PubMed
    118. Saxena V, Terrault N. Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies. Curr Opin Organ Transplant. 2012 Jun; 17(3):216-24. PMID: 22476221.
      View in: PubMed
    119. Terrault N, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26. PMID: 22328294; PMCID: PMC3358510.
    120. Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault N. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012 May; 18(5):532-8. PMID: 22271671; PMCID: PMC3334393.
    121. Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS, Stravitz RT, Trotter JF, Krishnan K, Terrault N. Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl. 2012 May; 18(5):524-31. PMID: 22140019; PMCID: PMC3314141.
    122. Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault N, Brown RS. Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. Liver Transpl. 2012 Apr; 18(4):461-7. PMID: 22467547; PMCID: PMC3674870.
    123. Lai JC, Roberts JP, Vittinghoff E, Terrault N, Feng S. Patient, center and geographic characteristics of nationally placed livers. Am J Transplant. 2012 Apr; 12(4):947-53. PMID: 22300591; PMCID: PMC3689311.
    124. Fox AN, Terrault N. The option of HBIG-free prophylaxis against recurrent HBV. J Hepatol. 2012 May; 56(5):1189-97. PMID: 22274310.
      View in: PubMed
    125. Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault N. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl. 2011 Dec; 17(12):1380-6. PMID: 21770018; PMCID: PMC3712627.
    126. Guy J, Kelley RK, Roberts J, Kerlan R, Yao F, Terrault N. Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):354-62. PMID: 22083023.
      View in: PubMed
    127. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011 Oct; 54(4):1313-21. PMID: 21688284; PMCID: PMC3184197.
    128. Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault N. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012 Jan; 32(1):158-64. PMID: 22098119.
      View in: PubMed
    129. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault N. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl. 2011 Aug; 17(8):955-62. PMID: 21462295.
      View in: PubMed
    130. Lai JC, Verna EC, Brown RS, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault N. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology. 2011 Aug; 54(2):418-24. PMID: 21538434; PMCID: PMC3144983.
    131. Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault N. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat. 2011 Jun; 18(6):415-23. PMID: 20626626; PMCID: PMC4142495.
    132. Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault N, Monto A. Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis. PLoS One. 2011; 6(5):e20104. PMID: 21637766; PMCID: PMC3103523.
    133. Bzowej N, Nelson DR, Terrault N, Everson GT, Teng LL, Prabhakar A, Charlton MR. PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl. 2011 May; 17(5):528-38. PMID: 21506241; PMCID: PMC3736350.
    134. Fox AN, Terrault N. Individualizing hepatitis B infection prophylaxis in liver transplant recipients. J Hepatol. 2011 Sep; 55(3):507-509. PMID: 21601598.
      View in: PubMed
    135. Trotter JF, Gillespie BW, Terrault N, Abecassis MM, Merion RM, Brown RS, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011 Apr; 17(4):409-17. PMID: 21445924; PMCID: PMC3295864.
    136. Lai JC, Feng S, Roberts JP, Terrault N. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant. 2011 Feb; 11(2):296-302. PMID: 21219572; PMCID: PMC3076602.
    137. Lai JC, Terrault N, Vittinghoff E, Biggins SW. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010 Dec; 10(12):2658-64. PMID: 21087414; PMCID: PMC3059496.
    138. Aytaman A, Kaufman M, Terrault N. Management of posttransplant hepatitis C infection. Curr Opin Organ Transplant. 2010 Jun; 15(3):301-9. PMID: 20445452.
      View in: PubMed
    139. Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis. 2010 Jun; 16(6):925-32. PMID: 20480515.
      View in: PubMed
    140. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault N, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010 May; 51(5):1514-22. PMID: 20169624; PMCID: PMC2946382.
    141. McHutchison JG, Manns MP, Muir AJ, Terrault N, Jacobson IM, Afdhal NH, Heathcote EJ, Zeuzem S, Reesink HW, Garg J, Bsharat M, George S, Kauffman RS, Adda N, Di Bisceglie AM. Telaprevir for previously treated chronic HCV infection. N Engl J Med. 2010 Apr 08; 362(14):1292-303. PMID: 20375406.
      View in: PubMed
    142. Sofair AN, Barry V, Manos MM, Thomas A, Zaman A, Terrault N, Murphy RC, Stabach N, Huie S, Van Ness G, Bell BP, Bialek S. The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. J Clin Gastroenterol. 2010 Apr; 44(4):301-7. PMID: 19745759.
      View in: PubMed
    143. Thomas DL, Di Bisceglie AM, Alter HJ, Terrault N. Understanding the natural history of chronic HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S17-22. PMID: 20398586.
      View in: PubMed
    144. Coffin CS, Stock PG, Dove LM, Berg CL, Nissen NN, Curry MP, Ragni M, Regenstein FG, Sherman KE, Roland ME, Terrault N. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant. 2010 May; 10(5):1268-75. PMID: 20346065; PMCID: PMC3155863.
    145. Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS, Terrault N, Hayashi PH, Hong JC. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg. 2010 Mar; 251(3):542-9. PMID: 20130466; PMCID: PMC3088992.
    146. Bacchetti P, Boylan RD, Terrault N, Monto A, Berenguer M. Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant. Int J Biostat. 2010 Feb 20; 6(1):Article 7. PMID: 20305705; PMCID: PMC2836212.
    147. Terrault N, Khalili M. A glimpse of future hepatitis C virus treatment paradigms. Hepatology. 2010 Feb; 51(2):707-10. PMID: 20104511.
      View in: PubMed
    148. Ferrucci LM, Bell BP, Dhotre KB, Manos MM, Terrault N, Zaman A, Murphy RC, Vanness GR, Thomas AR, Bialek SR, Desai MM, Sofair AN. Complementary and alternative medicine use in chronic liver disease patients. J Clin Gastroenterol. 2010 Feb; 44(2):e40-5. PMID: 19779363; PMCID: PMC3730290.
    149. Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, Seaberg E, Justman J, Levine AM, Mack WJ, Kovacs A. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS. 2009 Nov; 23(11):915-23. PMID: 19877800; PMCID: PMC2823487.
    150. Evon DM, Ramcharran D, Belle SH, Terrault N, Fontana RJ, Fried MW. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. Am J Gastroenterol. 2009 Dec; 104(12):2949-58. PMID: 19789525.
      View in: PubMed
    151. Hayman AV, Sofair AN, Manos MM, Thomas A, Terrault N, Ness GV, Stabach N, Robert M, Rumore G, Corless C, Bell B, Bialek S, Zaman A. Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis C. Medicine (Baltimore). 2009 Sep; 88(5):302-6. PMID: 19745689.
      View in: PubMed
    152. Kim WR, Terrault N, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009 Nov; 137(5):1680-6. PMID: 19632234; PMCID: PMC2910398.
    153. Behler CM, Terrault N, Etzell JE, Damon LE. Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Rep. 2009 Jul 06; 3:7335. PMID: 19830190; PMCID: PMC2737792.
    154. Valadao RM, Terrault N. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient? Liver Transpl. 2009 Jul; 15(7):677-81. PMID: 19562695.
      View in: PubMed
    155. Coffin CS, Terrault N. Management of patients co-infected with HBV and HCV. Expert Rev Anti Infect Ther. 2009 Jun; 7(5):549-58. PMID: 19485795.
      View in: PubMed
    156. Kuo A, Terrault N. Is recurrent hepatitis C worse with living donors? Curr Opin Organ Transplant. 2009 Jun; 14(3):240-4. PMID: 19395968.
      View in: PubMed
    157. Terrault N, Tran TT, Schiff E, McGuire BM, Brown RS, Tupper R, Ramanathan S, Enejosa J, Zhong L, Zong J. Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients. Liver Int. 2009 Sep; 29(8):1178-83. PMID: 19486291.
      View in: PubMed
    158. Terrault N. Benefits and risks of combination therapy for hepatitis B. Hepatology. 2009 May; 49(5 Suppl):S122-8. PMID: 19399796.
      View in: PubMed
    159. Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N. Transplant tourism to China: the impact on domestic patient-care decisions. Clin Transplant. 2009 Nov-Dec; 23(6):831-8. PMID: 19191815; PMCID: PMC2866030.
    160. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault N. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant. 2009 Feb; 9(2):301-8. PMID: 19120082; PMCID: PMC3732169.
    161. Nelson DR, Davis GL, Jacobson I, Everson GT, Fried MW, Harrison SA, Hassanein T, Jensen DM, Lindsay KL, Terrault N, Zein N. Hepatitis C virus: a critical appraisal of approaches to therapy. Clin Gastroenterol Hepatol. 2009 Apr; 7(4):397-414; quiz 366. PMID: 19114127.
      View in: PubMed
    162. Terrault N. Hepatitis C therapy before and after liver transplantation. Liver Transpl. 2008 Oct; 14 Suppl 2:S58-66. PMID: 18825697.
      View in: PubMed
    163. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault N. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008 Oct; 14(10):1491-7. PMID: 18825708.
      View in: PubMed
    164. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27. PMID: 18688876; PMCID: PMC4142499.
    165. Terrault N, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1403-11. PMID: 19081528; PMCID: PMC3166617.
    166. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialek SR, Sofair AN. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008 Nov; 103(11):2727-36; quiz 2737. PMID: 18684170.
      View in: PubMed
    167. Burton JR, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR. Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J Hepatol. 2008 Sep; 49(3):329-38. PMID: 18644644.
      View in: PubMed
    168. Howell CD, Dowling TC, Paul M, Wahed AS, Terrault N, Taylor M, Jeffers L, Hoofnagle JH. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clin Gastroenterol Hepatol. 2008 May; 6(5):575-83. PMID: 18407798; PMCID: PMC2704736.
    169. Manos MM, Leyden WA, Murphy RC, Terrault N, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology. 2008 Apr; 47(4):1150-7. PMID: 18264998.
      View in: PubMed
    170. Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault N, Bernardi M, Bertoletti A, Andreone P, Brander C. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection. Liver Transpl. 2008 Apr; 14(4):478-85. PMID: 18324666.
      View in: PubMed
    171. Samuel D, Weber R, Stock P, Duclos-Vallée JC, Terrault N. Are HIV-infected patients candidates for liver transplantation? J Hepatol. 2008 May; 48(5):697-707. PMID: 18331763.
      View in: PubMed
    172. Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault N. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75. PMID: 18166478; PMCID: PMC3184401.
    173. Irwin J, Terrault N. Cognitive impairment in hepatitis C patients on antiviral therapy. Gastroenterol Hepatol (N Y). 2008 Jan; 4(1):65-7. PMID: 22798739; PMCID: PMC3394472.
    174. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault N, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008 Feb; 8(2):355-65. PMID: 18093266.
      View in: PubMed
    175. Trotter JF, Wisniewski KA, Terrault N, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007 Nov; 46(5):1476-84. PMID: 17668879; PMCID: PMC3732162.
    176. Coffin CS, Terrault N. Management of hepatitis B in liver transplant recipients. J Viral Hepat. 2007 Nov; 14 Suppl 1:37-44. PMID: 17958641.
      View in: PubMed
    177. Terrault N, Jacobson IM. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy. Semin Liver Dis. 2007 Aug; 27 Suppl 1:18-24. PMID: 17701846.
      View in: PubMed
    178. Terrault N, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007 May; 2(3):563-75. PMID: 17699464.
      View in: PubMed
    179. Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann H, Samuel D, Zeuzem S, Villeneuve JP, Arterburn S, Borroto-Esoda K, Brosgart C, Chuck S. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl. 2007 Mar; 13(3):349-60. PMID: 17326221.
      View in: PubMed
    180. Kuo A, Terrault N. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters? J Hepatol. 2007 Mar; 46(3):359-61. PMID: 17223220.
      View in: PubMed
    181. Terrault N, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 Jan; 13(1):122-9. PMID: 17192908; PMCID: PMC3155862.
    182. Bialek SR, Terrault N. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis. 2006 Nov; 10(4):697-715. PMID: 17164113.
      View in: PubMed
    183. Galun E, Terrault N, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S. Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity. J Hepatol. 2007 Jan; 46(1):37-44. PMID: 17112624.
      View in: PubMed
    184. Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology. 2006 Oct; 44(4):925-35. PMID: 17006909.
      View in: PubMed
    185. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant. 2006 Sep-Oct; 20(5):617-23. PMID: 16968488; PMCID: PMC4050657.
    186. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault N, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 2006 Aug; 131(2):470-7. PMID: 16890601.
      View in: PubMed
    187. Terrault N, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl. 2006 Aug; 12(8):1192-204. PMID: 16868944.
      View in: PubMed
    188. Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology. 2006 May; 130(6):1636-42. PMID: 16697727.
      View in: PubMed
    189. Biggins SW, Kim WR, Terrault N, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006 May; 130(6):1652-60. PMID: 16697729.
      View in: PubMed
    190. Terrault N, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl. 2006 May; 12(5):801-7. PMID: 16628690.
      View in: PubMed
    191. Kuo A, Terrault N. Management of hepatitis C in liver transplant recipients. Am J Transplant. 2006 Mar; 6(3):449-58. PMID: 16468953.
      View in: PubMed
    192. Biggins SW, Terrault N. Management of recurrent hepatitis C in liver transplant recipients. Infect Dis Clin North Am. 2006 Mar; 20(1):155-74. PMID: 16527654.
      View in: PubMed
    193. Dickson RC, Terrault N, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS, Horwith G, Brundage R, Lok A. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl. 2006 Jan; 12(1):124-33. PMID: 16382463.
      View in: PubMed
    194. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault N. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant. 2006 Jan-Feb; 20(1):1-9. PMID: 16556146.
      View in: PubMed
    195. Terrault N. Treatment of recurrent hepatitis C in liver transplant recipients. Clin Gastroenterol Hepatol. 2005 Oct; 3(10 Suppl 2):S125-31. PMID: 16234060.
      View in: PubMed
    196. Terrault N, Pawlotsky JM, McHutchison J, Anderson F, Krajden M, Gordon S, Zitron I, Perrillo R, Gish R, Holodniy M, Friesenhahn M. Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy. J Viral Hepat. 2005 Sep; 12(5):465-72. PMID: 16108760.
      View in: PubMed
    197. Davis GL, Nelson DR, Terrault N, Pruett TL, Schiano TD, Fletcher CV, Sapan CV, Riser LN, Li Y, Whitley RJ, Gnann JW. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005 Aug; 11(8):941-9. PMID: 16035063.
      View in: PubMed
    198. Biggins SW, Terrault N. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis. 2005 Aug; 9(3):505-23, ix. PMID: 16023980.
      View in: PubMed
    199. Terrault N, Roche B, Samuel D. Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl. 2005 Jul; 11(7):716-32. PMID: 15973718.
      View in: PubMed
    200. Wong W, Terrault N. Update on chronic hepatitis C. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):507-20. PMID: 15952092.
      View in: PubMed
    201. Terrault N. Sex and hepatitis C. Am J Gastroenterol. 2005 Apr; 100(4):825-6. PMID: 15784026.
      View in: PubMed
    202. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, Terrault N. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology. 2005 Feb; 41(2):372-9. PMID: 15723436.
      View in: PubMed
    203. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault N. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005 Jan; 41(1):32-9. PMID: 15690479.
      View in: PubMed
    204. Patel D, Terrault N, Yao FY, Bass NM, Ladabaum U. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol. 2005 Jan; 3(1):75-84. PMID: 15645408.
      View in: PubMed
    205. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault N. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005 Jan; 5(1):118-24. PMID: 15636619.
      View in: PubMed
    206. Straley SD, Terrault N. Chronic Hepatitis B. Curr Treat Options Gastroenterol. 2004 Dec; 7(6):477-489. PMID: 15527714.
      View in: PubMed
    207. Bell BP, Mast EE, Terrault N, Hutin YJ. Prevention of hepatitis C in women. Emerg Infect Dis. 2004 Nov; 10(11):2035-6. PMID: 16010740; PMCID: PMC3329031.
    208. Lai CJ, Terrault N. Antiviral therapy in patients with chronic hepatitis B and cirrhosis. Gastroenterol Clin North Am. 2004 Sep; 33(3):629-54, x-xi. PMID: 15324948.
      View in: PubMed
    209. Chainani-Wu N, Lozada-Nur F, Terrault N. Hepatitis C virus and lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Aug; 98(2):171-83. PMID: 15316544.
      View in: PubMed
    210. McTaggart RA, Terrault N, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004 Aug; 10(8):975-85. PMID: 15390322.
      View in: PubMed
    211. French AL, Benning L, Anastos K, Augenbraun M, Nowicki M, Sathasivam K, Terrault N. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection. Clin Infect Dis. 2004 Aug 01; 39(3):402-10. PMID: 15307009.
      View in: PubMed
    212. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault N. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. PMID: 15004760.
      View in: PubMed
    213. Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R, Valsamakis A, Terrault N. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol. 2004 Feb; 42(2):563-9. PMID: 14766817; PMCID: PMC344448.
    214. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004 Jan; 39(1):230-8. PMID: 14752842.
      View in: PubMed
    215. Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology. 2003 Dec; 38(6):1419-27. PMID: 14647053.
      View in: PubMed
    216. Terrault N. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation. Liver Transpl. 2003 Nov; 9(11):S95-S100. PMID: 14586903.
      View in: PubMed
    217. Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg EC, French AL, Robison E, Nowicki M, Terrault N. Incident hepatitis C virus in women with human immunodeficiency virus infection. Clin Infect Dis. 2003 Nov 15; 37(10):1357-64. PMID: 14583870.
      View in: PubMed
    218. Roland ME, Adey D, Carlson LL, Terrault N. Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS. 2003 Oct; 17(10):501-7. PMID: 14588090.
      View in: PubMed
    219. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003 Sep; 38(3):619-28. PMID: 12939588.
      View in: PubMed
    220. Terrault N, Vyas G. Hepatitis B immune globulin preparations and use in liver transplantation. Clin Liver Dis. 2003 Aug; 7(3):537-50. PMID: 14509525.
      View in: PubMed
    221. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology. 2003 Aug; 125(2):444-51. PMID: 12891547.
      View in: PubMed
    222. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault N, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27; 76(2):370-5. PMID: 12883195.
      View in: PubMed
    223. Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med. 2003 Mar 24; 163(6):728-34. PMID: 12639207.
      View in: PubMed
    224. Biggins SW, Terrault N. Should HCV-related cirrhosis be a contraindication for retransplantation? Liver Transpl. 2003 Mar; 9(3):236-8. PMID: 12619019.
      View in: PubMed
    225. Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O'Connor KJ, Roth D, Terrault N, Henry ML. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation. 2002 Dec 27; 74(12):1657-63. PMID: 12499875.
      View in: PubMed
    226. Peters MG, Terrault N. Alcohol use and hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S220-5. PMID: 12407597; PMCID: PMC4123319.
    227. Terrault N. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S99-105. PMID: 12407582.
      View in: PubMed
    228. Terrault N. Motion - the available treatments for hepatitis C are cost effective: arguments for the motion. Can J Gastroenterol. 2002 Oct; 16(10):705-9. PMID: 12420032.
      View in: PubMed
    229. Terrault N. Treatment of recurrent hepatitis B infection in liver transplant recipients. Liver Transpl. 2002 Oct; 8(10 Suppl 1):S74-81. PMID: 12362303.
      View in: PubMed
    230. Kim WR, Brown RS, Terrault N, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42. PMID: 12085369.
      View in: PubMed
    231. Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl. 2002 Apr; 8(4):350-5. PMID: 11965579.
      View in: PubMed
    232. Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology. 2002 Mar; 35(3):673-9. PMID: 11870383.
      View in: PubMed
    233. Yao F, Terrault N. Hepatitis C and hepatocellular carcinoma. Curr Treat Options Oncol. 2001 Dec; 2(6):473-83. PMID: 12057093.
      View in: PubMed
    234. Terrault N. Chronic Hepatitis B. Curr Treat Options Gastroenterol. 2001 Dec; 4(6):493-502. PMID: 11696275.
      View in: PubMed
    235. Stock P, Roland M, Carlson L, Freise C, Hirose R, Terrault N, Frassetto L, Coates T, Roberts J, Ascher N. Solid organ transplantation in HIV-positive patients. Transplant Proc. 2001 Nov-Dec; 33(7-8):3646-8. PMID: 11750549.
      View in: PubMed
    236. Martino R, Terrault N, Ezerzer F, Mikulis D, Diamant NE. Dysphagia in a patient with lateral medullary syndrome: insight into the central control of swallowing. Gastroenterology. 2001 Aug; 121(2):420-6. PMID: 11487551.
      View in: PubMed
    237. Yao FY, Terrault N, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology. 2001 Aug; 34(2):411-6. PMID: 11481627.
      View in: PubMed
    238. Teo EK, Han SH, Terrault N, Luketic V, Jensen D, Keeffe EB, Lok AS. Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Hepatology. 2001 Jul; 34(1):126-32. PMID: 11431743.
      View in: PubMed
    239. Terrault N, Ma M. Adding to the hepatitis B virus treatment arsenal: alpha-glucosidase inhibitor derivatives. Hepatology. 2001 Jun; 33(6):1544-6. PMID: 11391545.
      View in: PubMed
    240. Terrault N. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection? Hepatology. 2000 Sep; 32(3):675-7. PMID: 10991635.
      View in: PubMed
    241. Terrault N. Hepatitis C virus and liver transplantation. Semin Gastrointest Dis. 2000 Apr; 11(2):96-114. PMID: 10803634.
      View in: PubMed
    242. Terrault N. Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges. Clin Transplant. 2000; 14 Suppl 2:39-43. PMID: 10965963.
      View in: PubMed
    243. Tong MJ, Terrault N, Klintmalm G. Hepatitis B transplantation: special conditions. Semin Liver Dis. 2000; 20 Suppl 1:25-8. PMID: 10895441.
      View in: PubMed
    244. Hassoba HM, Pessoa MG, Terrault N, Lewis NJ, Hayden M, Hunt JC, Qiu X, Lou SC, Wright TL. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model. J Med Virol. 1998 Nov; 56(3):253-8. PMID: 9783694.
      View in: PubMed
    245. Pessoa MG, Terrault N, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg. 1998 Nov; 4(6):461-8. PMID: 9791156.
      View in: PubMed
    246. Terrault N, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 1998 Aug; 28(2):555-61. PMID: 9696024.
      View in: PubMed
    247. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg. 1998 Jul; 4(4):304-10. PMID: 9649645.
      View in: PubMed
    248. Pessoa MG, Terrault N, Detmer J, Kolberg J, Collins M, Hassoba HM, Wright TL. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology. 1998 Mar; 27(3):877-80. PMID: 9500722.
      View in: PubMed
    249. Hassoba HM, Terrault N, el-Gohary AM, Scheffel C, Jou C, Brackett J, Hunt J, Lou SC, Wright TL. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity? J Med Virol. 1997 Dec; 53(4):354-60. PMID: 9407383.
      View in: PubMed
    250. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation. 1997 Aug 15; 64(3):410-4. PMID: 9275104.
      View in: PubMed
    251. Terrault N, Wright TL. Hepatitis B virus infection and liver transplantation. Gut. 1997 May; 40(5):568-71. PMID: 9203930; PMCID: PMC1027154.
    252. Pessoa MG, Terrault N, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 1997 May; 25(5):1266-70. PMID: 9141450.
      View in: PubMed
    253. Terrault N, Dailey PJ, Ferrell L, Collins ML, Wilber JC, Urdea MS, Bhandari BN, Wright TL. Hepatitis C virus: quantitation and distribution in liver. J Med Virol. 1997 Mar; 51(3):217-24. PMID: 9139087.
      View in: PubMed
    254. Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY. Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. Transplantation. 1997 Feb 27; 63(4):609-12. PMID: 9047160.
      View in: PubMed
    255. Ku NO, Wright TL, Terrault N, Gish R, Omary MB. Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest. 1997 Jan 01; 99(1):19-23. PMID: 9011570; PMCID: PMC507762.
    256. Terrault N, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec; 24(6):1327-33. PMID: 8938155.
      View in: PubMed
    257. Berenguer M, Terrault N, Piatak M, Yun A, Kim JP, Lau JY, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 1996 Dec; 111(6):1569-75. PMID: 8942736.
      View in: PubMed
    258. Zhou S, Terrault N, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov; 24(5):1041-6. PMID: 8903372.
      View in: PubMed
    259. Terrault N, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar; 2(2):132-8. PMID: 9346639.
      View in: PubMed
    260. Terrault N, Wright TL. Therapy for chronic hepatitis B infection. Adv Exp Med Biol. 1996; 394:189-205. PMID: 8815686.
      View in: PubMed
    261. Terrault N, Wright TL, Pereira BJ. Hepatitis C infection in the transplant recipient. Infect Dis Clin North Am. 1995 Dec; 9(4):943-64. PMID: 8747774.
      View in: PubMed
    262. Terrault N, Wright T. Interferon and hepatitis C. N Engl J Med. 1995 06 01; 332(22):1509-11. PMID: 7739691.
      View in: PubMed
    263. Terrault N, Wright TL. Hepatitis C virus in the setting of transplantation. Semin Liver Dis. 1995 Feb; 15(1):92-100. PMID: 7597448.
      View in: PubMed
    264. Terrault N, Feinman SV. Interferons for viral hepatitis. Transfus Med Rev. 1995 Jan; 9(1):29-52. PMID: 7536498.
      View in: PubMed
    265. Garcia G, Terrault N, Wright TL. Hepatitis C virus infection in the immunocompromised patient. Semin Gastrointest Dis. 1995 Jan; 6(1):35-45. PMID: 7894966.
      View in: PubMed
    Norah's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP